(Q55067043)

16 June 2018

title

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. (English)

1 reference

16 June 2018

1 reference

Thomas TC

1

1 reference

16 June 2018

Rollins SA

2

1 reference

16 June 2018

Rother RP

3

1 reference

16 June 2018

Giannoni MA

4

1 reference

16 June 2018

Hartman SL

5

1 reference

16 June 2018

Elliott EA

6

1 reference

16 June 2018

Nye SH

7

1 reference

16 June 2018

Matis LA

8

1 reference

16 June 2018

Squinto SP

9

1 reference

16 June 2018

Evans MJ

10

1 reference

16 June 2018

publication date

1 December 1996

1 reference

16 June 2018

published in

Molecular Immunology

1 reference

16 June 2018

volume

33

1 reference

16 June 2018

issue

17-18

1 reference

16 June 2018

page(s)

1389-1401

1 reference

16 June 2018

Canonical structures for the hypervariable regions of immunoglobulins

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Conformations of immunoglobulin hypervariable regions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

In vivo tumor targeting of a recombinant single-chain antigen-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

1 reference

7 January 2021

In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Rapid expression of an anti-human C5 chimeric Fab utilizing a vector that replicates in COS and 293 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Antibody framework residues affecting the conformation of the hypervariable loops

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Generation of a monoclonal antibody to mouse C5 application in an ELISA assay for detection of anti-CS antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Restriction fragment haplotypes in the human immunoglobulin IGHG locus and their correlation with the Gm polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Expressed human immunoglobulin kappa genes and their hypermutation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Mouse variable-region gene families: complexity, polymorphism and use in non-autoimmune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

The control of homologous lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Clinical complementology: recent progress and future trends

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

1 reference

7 January 2021

Inhibition of Terminal Complement Complex Formation and Cell Lysis by Monoclonal Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2896%2900078-8

7 January 2021

10.1016/S0161-5890(96)00078-8

Identifiers

DOI

1 reference

16 June 2018

PubMed ID

9171898

1 reference

16 June 2018